Therefore, while one study proposes FOXO3 downregulation to inhibit autophagy and chemosensitize HCC cells under hypoxia [22], the other one contrarily indicates that FOXO3 overexpression could overcome sorafenib resistance due to autophagy suppression [21]. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.